What this means for DFU care: Their anti-inflammatory, vascular, and neuroprotective properties could make GLP-1 receptor agonists a valuable adjunctive therapy in managing complex, chronic diabetic foot ulcers a hypothesis worth further exploration
Both are highly effective SGLT2 inhibitors with nearly identical mechanisms of action and clinical benefits
These findings provide a plausible neurophysiological basis for the lower incidence of nausea and vomiting observed with dual GIP/GLP-1 receptor agonists, such as tirzepatide, although the detailed molecular mechanisms remain to be elucidated
124,142 Investigations into mechanism of action-mediated pharmacokinetic DDIs are currently limited to those mediated by the slowing of gastric emptying, with examples summarized in other reviews
Patients in active cancer treatment should never start glutathione supplementation, oral or IV, without clearance from their oncologist